Literature DB >> 28069705

Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.

Anneline S J M Te Riele1,2,3, Esperanza Agullo-Pascual4, Cynthia A James1, Alejandra Leo-Macias4, Marina Cerrone4, Mingliang Zhang4, Xianming Lin4, Bin Lin4, Nara L Sobreira5, Nuria Amat-Alarcon1, Roos F Marsman6, Brittney Murray1, Crystal Tichnell1, Jeroen F van der Heijden2, Dennis Dooijes7, Toon A B van Veen8, Harikrishna Tandri1, Steven J Fowler4, Richard N W Hauer2,3, Gordon Tomaselli1, Maarten P van den Berg9, Matthew R G Taylor10, Francesca Brun11, Gianfranco Sinagra11, Arthur A M Wilde6, Luisa Mestroni10, Connie R Bezzina6, Hugh Calkins1, J Peter van Tintelen9,12,13, Lei Bu4,1, Mario Delmar4,1, Daniel P Judge14.   

Abstract

AIMS: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) is often associated with desmosomal mutations. Recent studies suggest an interaction between the desmosome and sodium channel protein Nav1.5. We aimed to determine the prevalence and biophysical properties of mutations in SCN5A (the gene encoding Nav1.5) in ARVD/C. METHODS AND
RESULTS: We performed whole-exome sequencing in six ARVD/C patients (33% male, 38.2 ± 12.1 years) without a desmosomal mutation. We found a rare missense variant (p.Arg1898His; R1898H) in SCN5A in one patient. We generated induced pluripotent stem cell-derived cardiomyocytes (hIPSC-CMs) from the patient's peripheral blood mononuclear cells. The variant was then corrected (R1898R) using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 technology, allowing us to study the impact of the R1898H substitution in the same cellular background. Whole-cell patch clamping revealed a 36% reduction in peak sodium current (P = 0.002); super-resolution fluorescence microscopy showed reduced abundance of NaV1.5 (P = 0.005) and N-Cadherin (P = 0.026) clusters at the intercalated disc. Subsequently, we sequenced SCN5A in an additional 281 ARVD/C patients (60% male, 34.8 ± 13.7 years, 52% desmosomal mutation-carriers). Five (1.8%) subjects harboured a putatively pathogenic SCN5A variant (p.Tyr416Cys, p.Leu729del, p.Arg1623Ter, p.Ser1787Asn, and p.Val2016Met). SCN5A variants were associated with prolonged QRS duration (119 ± 15 vs. 94 ± 14 ms, P < 0.01) and all SCN5A variant carriers had major structural abnormalities on cardiac imaging.
CONCLUSIONS: Almost 2% of ARVD/C patients harbour rare SCN5A variants. For one of these variants, we demonstrated reduced sodium current, Nav1.5 and N-Cadherin clusters at junctional sites. This suggests that Nav1.5 is in a functional complex with adhesion molecules, and reveals potential non-canonical mechanisms by which Nav1.5 dysfunction causes cardiomyopathy. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Arrhythmogenic right ventricular cardiomyopathy ; Cardiomyopathy ; Genetics ; Ion channel electrophysiology; SCN5A

Mesh:

Substances:

Year:  2017        PMID: 28069705      PMCID: PMC5220677          DOI: 10.1093/cvr/cvw234

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  30 in total

1.  Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts.

Authors:  Chuan Wang; Jessica A Hennessey; Robert D Kirkton; Chaojian Wang; Victoria Graham; Ram S Puranam; Paul B Rosenberg; Nenad Bursac; Geoffrey S Pitt
Journal:  Circ Res       Date:  2011-08-04       Impact factor: 17.367

2.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.

Authors:  Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba
Journal:  Eur Heart J       Date:  2010-02-19       Impact factor: 29.983

3.  Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members.

Authors:  Judith A Groeneweg; Aditya Bhonsale; Cynthia A James; Anneline S te Riele; Dennis Dooijes; Crystal Tichnell; Brittney Murray; Ans C P Wiesfeld; Abhishek C Sawant; Bina Kassamali; Douwe E Atsma; Paul G Volders; Natasja M de Groot; Karin de Boer; Stefan L Zimmerman; Ihab R Kamel; Jeroen F van der Heijden; Stuart D Russell; Maarten Jan Cramer; Ryan J Tedford; Pieter A Doevendans; Toon A van Veen; Harikrishna Tandri; Arthur A Wilde; Daniel P Judge; J Peter van Tintelen; Richard N Hauer; Hugh Calkins
Journal:  Circ Cardiovasc Genet       Date:  2015-03-27

4.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

5.  Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.

Authors:  Michael J Ackerman; Igor Splawski; Jonathan C Makielski; David J Tester; Melissa L Will; Katherine W Timothy; Mark T Keating; Gregg Jones; Monica Chadha; Christopher R Burrow; J Claiborne Stephens; Chuanbo Xu; Richard Judson; Mark E Curran
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

6.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.

Authors:  Aditya Bhonsale; Judith A Groeneweg; Cynthia A James; Dennis Dooijes; Crystal Tichnell; Jan D H Jongbloed; Brittney Murray; Anneline S J M te Riele; Maarten P van den Berg; Hennie Bikker; Douwe E Atsma; Natasja M de Groot; Arjan C Houweling; Jeroen F van der Heijden; Stuart D Russell; Pieter A Doevendans; Toon A van Veen; Harikrishna Tandri; Arthur A Wilde; Daniel P Judge; J Peter van Tintelen; Hugh Calkins; Richard N Hauer
Journal:  Eur Heart J       Date:  2015-01-23       Impact factor: 29.983

7.  Clinical role of atrial arrhythmias in patients with arrhythmogenic right ventricular dysplasia.

Authors:  Ardan M Saguner; Sabrina Ganahl; Andrea Kraus; Samuel H Baldinger; Argelia Medeiros-Domingo; Arhan R Saguner; Stephan A Mueller-Burri; Thomas Wolber; Laurent M Haegeli; Nazmi Krasniqi; Felix C Tanner; Jan Steffel; Corinna Brunckhorst; Firat Duru
Journal:  Circ J       Date:  2014-10-20       Impact factor: 2.993

8.  Tubulin polymerization modifies cardiac sodium channel expression and gating.

Authors:  Simona Casini; Hanno L Tan; Ilker Demirayak; Carol Ann Remme; Ahmad S Amin; Brendon P Scicluna; Houssine Chatyan; Jan M Ruijter; Connie R Bezzina; Antoni C G van Ginneken; Marieke W Veldkamp
Journal:  Cardiovasc Res       Date:  2009-10-26       Impact factor: 10.787

9.  PDZ domain-binding motif regulates cardiomyocyte compartment-specific NaV1.5 channel expression and function.

Authors:  Diana Shy; Ludovic Gillet; Jakob Ogrodnik; Maxime Albesa; Arie O Verkerk; Rianne Wolswinkel; Jean-Sébastien Rougier; Julien Barc; Maria C Essers; Ninda Syam; Roos F Marsman; Anneke M van Mil; Samuel Rotman; Richard Redon; Connie R Bezzina; Carol Ann Remme; Hugues Abriel
Journal:  Circulation       Date:  2014-06-03       Impact factor: 29.690

10.  Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.

Authors:  Marina Cerrone; Xianming Lin; Mingliang Zhang; Esperanza Agullo-Pascual; Anna Pfenniger; Halina Chkourko Gusky; Valeria Novelli; Changsung Kim; Tiara Tirasawadichai; Daniel P Judge; Eli Rothenberg; Huei-Sheng Vincent Chen; Carlo Napolitano; Silvia G Priori; Mario Delmar
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

View more
  61 in total

Review 1.  The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.

Authors:  Lingqun Ye; Xuan Ni; Zhen-Ao Zhao; Wei Lei; Shijun Hu
Journal:  J Cardiovasc Transl Res       Date:  2018-05-29       Impact factor: 4.132

Review 2.  Unmasking the molecular link between arrhythmogenic cardiomyopathy and Brugada syndrome.

Authors:  Javier Moncayo-Arlandi; Ramon Brugada
Journal:  Nat Rev Cardiol       Date:  2017-07-13       Impact factor: 32.419

3.  Genetic basis and molecular biology of cardiac arrhythmias in cardiomyopathies.

Authors:  Ali J Marian; Babken Asatryan; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 4.  Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders

Authors:  Marina Cerrone; Carol Ann Remme; Rafik Tadros; Connie R Bezzina; Mario Delmar
Journal:  Circulation       Date:  2019-08-12       Impact factor: 29.690

5.  Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Fanis Buljubasic; Ibrahim El-Battrawy; Huan Lan; Santosh K Lomada; Anupriya Chatterjee; Zhihan Zhao; Xin Li; Rujia Zhong; Qiang Xu; Mengying Huang; Zhenxing Liao; Siegfried Lang; Lukas Cyganek; Xiaobo Zhou; Thomas Wieland; Martin Borggrefe; Ibrahim Akin
Journal:  J Clin Med       Date:  2020-02-10       Impact factor: 4.241

Review 6.  Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Authors:  Perry M Elliott; Aris Anastasakis; Angeliki Asimaki; Cristina Basso; Barbara Bauce; Matthew A Brooke; Hugh Calkins; Domenico Corrado; Firat Duru; Kathleen J Green; Daniel P Judge; David Kelsell; Pier D Lambiase; William J McKenna; Kalliopi Pilichou; Alexandros Protonotarios; Jeffrey E Saffitz; Petros Syrris; Hari Tandri; Anneline Te Riele; Gaetano Thiene; Adalena Tsatsopoulou; J Peter van Tintelen
Journal:  Eur J Heart Fail       Date:  2019-06-18       Impact factor: 15.534

Review 7.  Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential.

Authors:  Alain van Mil; Geerthe Margriet Balk; Klaus Neef; Jan Willem Buikema; Folkert W Asselbergs; Sean M Wu; Pieter A Doevendans; Joost P G Sluijter
Journal:  Cardiovasc Res       Date:  2018-12-01       Impact factor: 10.787

8.  Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.

Authors:  Jennifer Karmouch; Qiong Q Zhou; Christina Y Miyake; Raffaella Lombardi; Kai Kretzschmar; Marie Bannier-Hélaouët; Hans Clevers; Xander H T Wehrens; James T Willerson; Ali J Marian
Journal:  Circ Res       Date:  2017-10-10       Impact factor: 17.367

Review 9.  Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Anita Kiran Vimalanathan; Elisabeth Ehler; Katja Gehmlich
Journal:  Biophys Rev       Date:  2018-07-11

10.  Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.

Authors:  Alice Ghidoni; Perry M Elliott; Petros Syrris; Hugh Calkins; Cynthia A James; Daniel P Judge; Brittney Murray; Julien Barc; Vincent Probst; Jean Jacques Schott; Jiang-Ping Song; Richard N W Hauer; Edgar T Hoorntje; J Peter van Tintelen; Eric Schulze-Bahr; Robert M Hamilton; Kirti Mittal; Christopher Semsarian; Elijah R Behr; Michael J Ackerman; Cristina Basso; Gianfranco Parati; Davide Gentilini; Maria-Christina Kotta; Bongani M Mayosi; Peter J Schwartz; Lia Crotti
Journal:  Circ Genom Precis Med       Date:  2021-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.